Knowledge (XXG)

Sodium hyaluronate

Source 📝

165: 142: 31: 388:
relief, by recovering the viscoelasticity of the articular fluid, and by stimulating new production of synovial fluid. Use of sodium hyaluronate may reduce the need for joint replacement. Injections appear to increase in effectiveness over the course of four weeks, reaching a peak at eight weeks and
470:
Topically applied sodium hyaluronate can facilitate the absorption of biomacromolecules, i.e. pharmaceuticals, and function like a nanocarrier. Its effects on skin depend on the hyaluronate formulation and skin health: In barrier-deficient skin it restricted the delivery of biomacromolecules to the
440:
and other surrounding tissues. Its viscoelasticity also helps to push back the vitreous face and prevent formation of a postoperative flat chamber. In posterior segment surgery, sodium hyaluronate serves as a surgical aid to gently separate, maneuver, and hold tissues. It creates a clear field of
305:
and is thought to play an important role in modulating the interactions between adjacent tissues. It forms a viscoelastic solution in water. Mechanical protection for tissues (iris, retina) and cell layers (corneal, endothelium, and epithelium) are provided by the high viscosity of the solution.
461:
on the face. As of 2017, the FDA had approved 13 hyaluronate preparations as so called dermal fillers. They are also used as a filler of lips or in other parts of the body, though not FDA approved. The filling effect is temporary and lasts for about six months or longer in most people.
310:
for tissues. In facilitating wound healing, it is thought that it acts as a protective transport vehicle, taking peptide growth factors and other structural proteins to a site of action. It is then enzymatically degraded and active proteins are released to promote tissue repair.
488:
After instillation into the lung, higher molecular weight hyaluronate appears to persist longer in the lung but if > 215 kD there was poor lung penetration and mucociliary clearance. Hyaluronate could allow access to lymph nodes draining the pulmonary bed.
533:
In the late 1970s and early 1980s the material was used with the brand names of Hylartin and Hylartin Vetused in human and veterinary clinical trials (race horses) to treat osteoarthritis. The first commercially sold sodium hyaluronate had been developed by
433:, instillation of sodium hyaluronate its viscoelasticity enables maintenance of a deep chamber during surgical manipulation since the solution does not flow out of the open anterior chamber, allowing for efficient manipulation with less trauma to the 367:
who have not received relief from other treatments. It is injected into the joint capsule, to act as both a shock absorber and a lubricant for the joint. Thus sodium hyaluronate is used as a viscosupplement, administered through a series of
1440: 538:
under the brand name of Healon, manufactured by Pharmacia AB in Sweden in 1980. In 1986, sodium hyaluronate was used as an intra-articular injection to treat osteoarthritis of the knee with the product Hyalart/Hyalgan by Fidia of Italy.
582:
Boucher WS, Letourneau R, Huang M, Kempuraj D, Green M, Sant GR, Theoharides TC (January 2002). "Intravesical sodium hyaluronate inhibits the rat urinary mast cell mediator increase triggered by acute immobilization stress".
621:
Jubb RW, Piva S, Beinat L, Dacre J, Gishen P (2003). "A one-year, randomised, placebo (saline) controlled clinical trial of 500-730 kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee".
694:
Bannuru RR, Schmid CH, Kent DM, Vaysbrot EE, Wong JB, McAlindon TE (January 2015). "Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis".
474:
Transepidermal water loss increased by 55.5% with low-molecular weight, and was reduced by 28% with crosslinked resilient, and by 16% with HMW. Its efficacy against wrinkles has not been tested in clinical trials.
1165:
Witting M, Boreham A, Brodwolf R, Vávrová K, Alexiev U, Friess W, Hedtrich S (May 2015). "Interactions of hyaluronic Acid with the skin and implications for the dermal delivery of biomacromolecules".
1444: 945:
Salk RS, Chang TJ, D'Costa WF, Soomekh DJ, Grogan KA (February 2006). "Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double-blind pilot study".
1202:"Pilot Comparative Study of the Topical Action of a Novel, Crosslinked Resilient Hyaluronic Acid on Skin Hydration and Barrier Function in a Dynamic, Three-Dimensional Human Explant Model" 174: 838:"Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study" 53: 1475: 525:
preparations. If being administered as an intra-articular injection, it should not be given when there are infections or skin disease at the injection site.
319:
Sodium hyaluronate is cleared within hours of injection but appears to have residual effects on contacted cells. In the eye it is eliminated via the
1045: 1424: 1343: 471:
stratum corneum and viable epidermis. In normal skin, low-molecular weight hyaluronate (5 kDa) enhanced penetration into the epidermis.
877:
Kotz R, Kolarz G (November 1999). "Intra-articular hyaluronic acid: duration of effect and results of repeated treatment cycles".
553: 1468: 384:, which helps lubricate, cushion and reduce pain in the joint. It is generally used as a last resort before surgery and provides 79: 1577: 1603: 521:
Sodium hyaluronate has a very low incidence of side effects, however it is contraindicated in people who are sensitive to
1232: 1598: 1461: 430: 121: 1441:"Fidia Farmaceutici S.p.A. to Distribute and Promote HYALGAN® (sodium hyaluronate) for Treatment of Osteoarthritis" 906:"Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis--meta-analysis" 485:, may be treated with lotion or another skin product containing sodium hyaluronate as its active ingredient. 510: 239: 160: 535: 446: 429:
filtration, and retina attachment surgery and in the treatment of dry eyes. In surgical procedures in the
548: 502: 238:
units of Na-glucuronate-N-acetylglucosamine. It can bind to specific receptors for which it has a high
369: 347: 274: 137: 1528: 1274:"Hyaluronic Acid Molecular Weight Determines Lung Clearance and Biodistribution after Instillation" 414: 290: 1102: 1084: 720: 647: 422: 320: 1488: 1420: 1390: 1365: 1303: 1213: 1201: 1182: 1147: 1076: 1059:
Beasley KL, Weiss MA, Weiss RA (May 2009). "Hyaluronic acid fillers: a comprehensive review".
1011: 962: 927: 886: 859: 818: 769: 712: 639: 600: 506: 482: 389:
retaining some effectiveness at six months, with greater benefit for osteoarthritis than oral
282: 278: 227: 207: 203: 43: 306:
Elasticity of the solution assists in absorbing mechanical stress and providing a protective
1533: 1293: 1285: 1174: 1137: 1129: 1116:
Wickens JM, Alsaab HO, Kesharwani P, Bhise K, Amin MC, Tekade RK, et al. (April 2017).
1068: 1001: 993: 954: 917: 849: 808: 800: 759: 751: 704: 631: 592: 418: 406: 1028: 563: 497:
Sodium hyaluronate can be instilled into the bladder for the treatment of various forms of
1545: 1540: 980:
Shimmura S, Ono M, Shinozaki K, Toda I, Takamura E, Mashima Y, Tsubota K (November 1995).
410: 307: 258: 250: 223: 199: 1272:
Kuehl C, Zhang T, Kaminskas LM, Porter CJ, Davies NM, Forrest L, Berkland C (June 2016).
164: 141: 1484: 1298: 1273: 1142: 1118:"Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy" 1117: 813: 788: 764: 739: 635: 381: 364: 343: 254: 1453: 1289: 1200:
Sundaram H, Mackiewicz N, Burton E, Peno-Mazzarino L, Lati E, Meunier S (April 2016).
1006: 981: 854: 837: 740:"Relative efficacy of knee osteoarthritis treatments: are all placebos created equal?" 596: 1592: 724: 334:
When used in ophthalmological procedures, sodium hyaluronate may cause postoperative
286: 153: 1088: 665: 651: 110: 63: 335: 235: 22: 30: 1133: 1523: 1046:"Soft Tissue Fillers Approved by the Center for Devices and Radiological Health" 522: 437: 402: 922: 905: 1502: 246: 1321: 1250: 390: 377: 302: 57: 1307: 1217: 1186: 1151: 1080: 1072: 997: 966: 931: 890: 863: 773: 716: 643: 604: 1015: 822: 441:
vision, facilitating intra-operative and post-operative inspection of the
1417:
History of Hyaluroan Science: From Basic Science to Clinical Applications
958: 804: 498: 426: 385: 1561: 478: 458: 231: 96: 1178: 1035:. (Updated 8 December 2004). RxList, Inc. Retrieved 25 February 2014. 755: 708: 442: 434: 273:
Sodium hyaluronate, as hyaluronic acid, is distributed widely in the
219: 195: 904:
Bannuru RR, Natov NS, Dasi UR, Schmid CH, McAlindon TE (June 2011).
331:
Adverse effects are relatively rare when used to treat the joints.
339: 262: 373: 1457: 558: 1031:. (2002). Kalamazoo, Michigan: Pharmacia Corporation. (Web). 48:
Healon, Provisc, Viscoat, Hyalgan, Euflexxa, Supartz, Gel-One
393:. It may also be effective when used with the ankle joint. 126: 982:"Sodium hyaluronate eyedrops in the treatment of dry eyes" 789:"Intra-articular hyaluronan treatment for osteoarthritis" 666:"Hyaluronate sodium: Indications, Side Effects, Warnings" 1366:"Bladder Instillation of Cystistat (sodium hyaluronate)" 181: 947:
The Journal of Bone and Joint Surgery. American Volume
836:
Karlsson J, Sjögren LS, Lohmander LS (November 2002).
1391:"Patient Information Triluron™ (Sodium Hyaluronate)" 1371:. East Sussex Healthcare NHS Trust. 5 September 2020 1570: 1554: 1516: 1495: 152: 120: 95: 70: 52: 42: 37: 1443:. Fidia Pharma. 26 September 2011. Archived from 1251:"Hylira gel: Indications, Side Effects, Warnings" 1105:. U.S. Food and Drug Administration. 2016-12-20. 1048:. U.S. Food and Drug Administration. 2015-07-27. 109: 363:It is used to treat knee pain in patients with 616: 614: 245:The polyanionic form, commonly referred to as 1469: 8: 1415:Hargittai M, Hargittai I, Balazs EA (2011). 261:of the eye and in the fluid of articulating 21: 1476: 1462: 1454: 624:International Journal of Clinical Practice 163: 140: 29: 1297: 1141: 1005: 921: 853: 812: 763: 457:Sodium hyaluronate is injected to reduce 301:Sodium hyaluronate functions as a tissue 1233:"Makeup gets in on the anti-aging craze" 574: 136: 84: 154: 20: 62: 7: 986:The British Journal of Ophthalmology 738:Mandl LA, Losina E (January 2015). 100: 636:10.1111/j.1742-1241.2003.tb10535.x 453:Skin injections in plastic surgery 397:Intraocular viscoelastic injection 14: 1290:10.1021/acs.molpharmaceut.6b00069 793:Annals of the Rheumatic Diseases 1322:"Hyacyst® (sodium hyaluronate)" 1206:Journal of Drugs in Dermatology 879:American Journal of Orthopedics 855:10.1093/rheumatology/41.11.1240 1578:Polysulfated glycosaminoglycan 787:Puhl W, Scharf P (July 1997). 346:, and short-term increases in 1: 1253:. Drugs.com. 14 February 2019 1029:"Healon (Sodium Hyaluronate)" 597:10.1016/S0022-5347(05)65472-9 1134:10.1016/j.drudis.2016.12.009 1103:"Filling in Wrinkles Safely" 910:Osteoarthritis and Cartilage 417:(intra- and extracapsular), 1231:Stukin S (27 August 2009). 744:Annals of Internal Medicine 697:Annals of Internal Medicine 549:Hyaluronic acid sodium salt 431:anterior segment of eyeball 64:Multum Consumer Information 1620: 1419:. Vol. 2. Pubmatrix. 1324:. Syner-Med. November 2021 923:10.1016/j.joca.2010.09.014 218:Sodium hyaluronate is the 1496:Unsulfated, extracellular 1346:. Bladder Health UK. 2022 493:Intravesical instillation 481:, such as that caused by 401:It is used as an aid in 359:Intra-articular injection 171: 75: 28: 1396:. Fidia Pharma USA. 2019 1555:Sulfated, intracellular 1517:Sulfated, extracellular 1278:Molecular Pharmaceutics 1167:Molecular Pharmaceutics 554:Biochem/physiol Actions 1073:10.1055/s-0029-1220647 1061:Facial Plastic Surgery 998:10.1136/bjo.79.11.1007 585:The Journal of Urology 536:Endre Alexander Balazs 505:, by replenishing the 253:polymer found in the 1604:Organic sodium salts 1122:Drug Discovery Today 959:10.2106/JBJS.E.00193 805:10.1136/ard.56.7.441 348:intraocular pressure 275:extracellular matrix 1529:Chondroitin sulfate 466:Topical application 415:cataract extraction 297:Mechanism of action 291:corneal endothelium 25: 1599:Glycosaminoglycans 1508:Sodium hyaluronate 1489:glycosaminoglycans 511:bladder urothelium 423:corneal transplant 403:ophthalmic surgery 269:Natural occurrence 192:Sodium hyaluronate 23:Sodium hyaluronate 1586: 1585: 1426:978-0-9820350-4-7 1179:10.1021/mp500676e 992:(11): 1007–1011. 885:(11 Suppl): 5–7. 848:(11): 1240–1248. 675:. 5 February 2014 564:Legal Information 517:Contraindications 507:glycosaminoglycan 483:atopic dermatitis 376:, increasing the 289:, as well as the 228:glycosaminoglycan 208:connective tissue 206:found in various 204:glycosaminoglycan 189: 188: 122:CompTox Dashboard 87:Hyaluronan Sodium 16:Chemical compound 1611: 1534:Dermatan sulfate 1478: 1471: 1464: 1455: 1449: 1448: 1447:on 27 July 2014. 1437: 1431: 1430: 1412: 1406: 1405: 1403: 1401: 1395: 1387: 1381: 1380: 1378: 1376: 1370: 1362: 1356: 1355: 1353: 1351: 1340: 1334: 1333: 1331: 1329: 1318: 1312: 1311: 1301: 1284:(6): 1904–1914. 1269: 1263: 1262: 1260: 1258: 1247: 1241: 1240: 1228: 1222: 1221: 1197: 1191: 1190: 1173:(5): 1391–1401. 1162: 1156: 1155: 1145: 1113: 1107: 1106: 1099: 1093: 1092: 1056: 1050: 1049: 1042: 1036: 1026: 1020: 1019: 1009: 977: 971: 970: 942: 936: 935: 925: 901: 895: 894: 874: 868: 867: 857: 833: 827: 826: 816: 784: 778: 777: 767: 756:10.7326/M14-2636 735: 729: 728: 709:10.7326/M14-1231 691: 685: 684: 682: 680: 670: 662: 656: 655: 618: 609: 608: 579: 447:photocoagulation 419:intraocular lens 321:canal of Schlemm 315:Pharmacokinetics 185: 184: 177: 167: 156: 145: 144: 130: 128: 113: 103: 102: 66: 33: 26: 24: 1619: 1618: 1614: 1613: 1612: 1610: 1609: 1608: 1589: 1588: 1587: 1582: 1566: 1550: 1546:Keratan sulfate 1541:Heparan sulfate 1512: 1491: 1485:Polysaccharides 1482: 1452: 1439: 1438: 1434: 1427: 1414: 1413: 1409: 1399: 1397: 1393: 1389: 1388: 1384: 1374: 1372: 1368: 1364: 1363: 1359: 1349: 1347: 1342: 1341: 1337: 1327: 1325: 1320: 1319: 1315: 1271: 1270: 1266: 1256: 1254: 1249: 1248: 1244: 1230: 1229: 1225: 1199: 1198: 1194: 1164: 1163: 1159: 1115: 1114: 1110: 1101: 1100: 1096: 1058: 1057: 1053: 1044: 1043: 1039: 1027: 1023: 979: 978: 974: 944: 943: 939: 903: 902: 898: 876: 875: 871: 835: 834: 830: 786: 785: 781: 737: 736: 732: 693: 692: 688: 678: 676: 668: 664: 663: 659: 620: 619: 612: 581: 580: 576: 572: 559:Hyaluronic Acid 545: 531: 519: 501:and associated 495: 479:Dry, scaly skin 468: 455: 399: 361: 356: 329: 327:Adverse effects 317: 299: 271: 259:vitreous humour 230:and long-chain 224:hyaluronic acid 216: 200:hyaluronic acid 180: 178: 175:(what is this?) 172: 148: 124: 116: 99: 91: 88: 83: 82: 17: 12: 11: 5: 1617: 1615: 1607: 1606: 1601: 1591: 1590: 1584: 1583: 1581: 1580: 1574: 1572: 1568: 1567: 1565: 1564: 1558: 1556: 1552: 1551: 1549: 1548: 1543: 1538: 1537: 1536: 1531: 1520: 1518: 1514: 1513: 1511: 1510: 1505: 1499: 1497: 1493: 1492: 1483: 1481: 1480: 1473: 1466: 1458: 1451: 1450: 1432: 1425: 1407: 1382: 1357: 1335: 1313: 1264: 1242: 1223: 1212:(4): 434–441. 1192: 1157: 1128:(4): 665–680. 1108: 1094: 1051: 1037: 1021: 972: 953:(2): 295–302. 937: 916:(6): 611–619. 896: 869: 828: 779: 730: 686: 657: 630:(6): 467–474. 610: 591:(1): 380–384. 573: 571: 568: 567: 566: 561: 556: 551: 544: 541: 530: 527: 518: 515: 494: 491: 467: 464: 454: 451: 421:implantation, 411:vitreous humor 398: 395: 382:synovial fluid 365:osteoarthritis 360: 357: 355: 352: 344:decompensation 328: 325: 316: 313: 298: 295: 287:neural tissues 270: 267: 215: 212: 187: 186: 169: 168: 158: 150: 149: 147: 146: 138:DTXSID30238233 133: 131: 118: 117: 115: 114: 106: 104: 93: 92: 90: 89: 86: 78: 77: 76: 73: 72: 68: 67: 60: 50: 49: 46: 40: 39: 35: 34: 15: 13: 10: 9: 6: 4: 3: 2: 1616: 1605: 1602: 1600: 1597: 1596: 1594: 1579: 1576: 1575: 1573: 1569: 1563: 1560: 1559: 1557: 1553: 1547: 1544: 1542: 1539: 1535: 1532: 1530: 1527: 1526: 1525: 1522: 1521: 1519: 1515: 1509: 1506: 1504: 1501: 1500: 1498: 1494: 1490: 1486: 1479: 1474: 1472: 1467: 1465: 1460: 1459: 1456: 1446: 1442: 1436: 1433: 1428: 1422: 1418: 1411: 1408: 1392: 1386: 1383: 1367: 1361: 1358: 1345: 1339: 1336: 1323: 1317: 1314: 1309: 1305: 1300: 1295: 1291: 1287: 1283: 1279: 1275: 1268: 1265: 1252: 1246: 1243: 1238: 1234: 1227: 1224: 1219: 1215: 1211: 1207: 1203: 1196: 1193: 1188: 1184: 1180: 1176: 1172: 1168: 1161: 1158: 1153: 1149: 1144: 1139: 1135: 1131: 1127: 1123: 1119: 1112: 1109: 1104: 1098: 1095: 1090: 1086: 1082: 1078: 1074: 1070: 1066: 1062: 1055: 1052: 1047: 1041: 1038: 1034: 1030: 1025: 1022: 1017: 1013: 1008: 1003: 999: 995: 991: 987: 983: 976: 973: 968: 964: 960: 956: 952: 948: 941: 938: 933: 929: 924: 919: 915: 911: 907: 900: 897: 892: 888: 884: 880: 873: 870: 865: 861: 856: 851: 847: 843: 839: 832: 829: 824: 820: 815: 810: 806: 802: 798: 794: 790: 783: 780: 775: 771: 766: 761: 757: 753: 749: 745: 741: 734: 731: 726: 722: 718: 714: 710: 706: 702: 698: 690: 687: 674: 667: 661: 658: 653: 649: 645: 641: 637: 633: 629: 625: 617: 615: 611: 606: 602: 598: 594: 590: 586: 578: 575: 569: 565: 562: 560: 557: 555: 552: 550: 547: 546: 542: 540: 537: 528: 526: 524: 516: 514: 512: 509:layer of the 508: 504: 500: 492: 490: 486: 484: 480: 476: 472: 465: 463: 460: 452: 450: 448: 444: 439: 436: 432: 428: 424: 420: 416: 412: 408: 404: 396: 394: 392: 387: 383: 379: 375: 371: 366: 358: 353: 351: 349: 345: 341: 337: 332: 326: 324: 322: 314: 312: 309: 304: 296: 294: 292: 288: 284: 280: 277:of mammalian 276: 268: 266: 264: 260: 256: 252: 251:visco-elastic 248: 243: 241: 237: 233: 229: 225: 221: 213: 211: 209: 205: 201: 197: 193: 183: 176: 170: 166: 162: 159: 157: 155:ECHA InfoCard 151: 143: 139: 135: 134: 132: 123: 119: 112: 108: 107: 105: 98: 94: 85: 81: 74: 69: 65: 61: 59: 55: 51: 47: 45: 41: 38:Clinical data 36: 32: 27: 19: 1507: 1445:the original 1435: 1416: 1410: 1400:29 September 1398:. Retrieved 1385: 1375:29 September 1373:. Retrieved 1360: 1350:29 September 1348:. Retrieved 1344:"Cystistat®" 1338: 1328:29 September 1326:. Retrieved 1316: 1281: 1277: 1267: 1255:. Retrieved 1245: 1237:The LA Times 1236: 1226: 1209: 1205: 1195: 1170: 1166: 1160: 1125: 1121: 1111: 1097: 1067:(2): 86–94. 1064: 1060: 1054: 1040: 1032: 1024: 989: 985: 975: 950: 946: 940: 913: 909: 899: 882: 878: 872: 845: 842:Rheumatology 841: 831: 796: 792: 782: 750:(1): 71–72. 747: 743: 733: 703:(1): 46–54. 700: 696: 689: 677:. Retrieved 672: 660: 627: 623: 588: 584: 577: 532: 520: 503:bladder pain 496: 487: 477: 473: 469: 456: 400: 362: 354:Medical uses 336:inflammation 333: 330: 318: 300: 272: 244: 236:disaccharide 217: 191: 190: 179:   173:   18: 1524:Chondroitin 679:25 February 523:hyaluronate 438:endothelium 386:symptomatic 210:of humans. 161:100.130.288 71:Identifiers 44:Trade names 1593:Categories 1503:Hyaluronan 799:(7): 441. 570:References 413:, e.g. in 405:acting as 391:analgesics 370:injections 338:, corneal 283:epithelial 279:connective 247:hyaluronan 226:. It is a 80:IUPAC name 1571:Synthetic 725:207538194 673:Drugs.com 378:viscosity 372:into the 303:lubricant 214:Chemistry 58:Drugs.com 1308:27157508 1257:16 March 1218:27050698 1187:25871518 1152:28017836 1089:12498280 1081:19415575 967:16452740 932:21443958 891:10587245 864:12421996 774:25560716 717:25560713 652:28214461 644:12918884 605:11743360 543:See also 499:cystitis 459:wrinkles 427:glaucoma 240:affinity 222:salt of 198:salt of 182:(verify) 1562:Heparin 1299:5200957 1143:5413407 1016:8534643 823:9486013 814:1752402 765:4545522 529:History 435:corneal 407:aqueous 380:of the 255:aqueous 249:, is a 232:polymer 194:is the 111:3084049 97:PubChem 1423:  1306:  1296:  1216:  1185:  1150:  1140:  1087:  1079:  1033:RxList 1014:  1007:505317 1004:  965:  930:  889:  862:  821:  811:  772:  762:  723:  715:  650:  642:  603:  443:retina 308:buffer 285:, and 263:joints 220:sodium 196:sodium 1394:(PDF) 1369:(PDF) 1085:S2CID 721:S2CID 669:(Web) 648:S2CID 340:edema 1421:ISBN 1402:2022 1377:2022 1352:2022 1330:2022 1304:PMID 1259:2019 1214:PMID 1183:PMID 1148:PMID 1077:PMID 1012:PMID 963:PMID 928:PMID 887:PMID 860:PMID 819:PMID 770:PMID 713:PMID 681:2014 640:PMID 601:PMID 445:and 409:and 374:knee 257:and 202:, a 54:AHFS 1294:PMC 1286:doi 1175:doi 1138:PMC 1130:doi 1069:doi 1002:PMC 994:doi 955:doi 918:doi 850:doi 809:PMC 801:doi 760:PMC 752:doi 748:162 705:doi 701:162 632:doi 593:doi 589:167 513:. 342:or 234:of 127:EPA 101:CID 1595:: 1487:: 1302:. 1292:. 1282:13 1280:. 1276:. 1235:. 1210:15 1208:. 1204:. 1181:. 1171:12 1169:. 1146:. 1136:. 1126:22 1124:. 1120:. 1083:. 1075:. 1065:25 1063:. 1010:. 1000:. 990:79 988:. 984:. 961:. 951:88 949:. 926:. 914:19 912:. 908:. 883:28 881:. 858:. 846:41 844:. 840:. 817:. 807:. 797:56 795:. 791:. 768:. 758:. 746:. 742:. 719:. 711:. 699:. 671:. 646:. 638:. 628:57 626:. 613:^ 599:. 587:. 449:. 425:, 350:. 323:. 293:. 281:, 265:. 242:. 1477:e 1470:t 1463:v 1429:. 1404:. 1379:. 1354:. 1332:. 1310:. 1288:: 1261:. 1239:. 1220:. 1189:. 1177:: 1154:. 1132:: 1091:. 1071:: 1018:. 996:: 969:. 957:: 934:. 920:: 893:. 866:. 852:: 825:. 803:: 776:. 754:: 727:. 707:: 683:. 654:. 634:: 607:. 595:: 129:) 125:( 56:/

Index


Trade names
AHFS
Drugs.com
Multum Consumer Information
IUPAC name
PubChem
3084049
CompTox Dashboard
DTXSID30238233
Edit this at Wikidata
ECHA InfoCard
100.130.288
Edit this at Wikidata
(what is this?)
(verify)
sodium
hyaluronic acid
glycosaminoglycan
connective tissue
sodium
hyaluronic acid
glycosaminoglycan
polymer
disaccharide
affinity
hyaluronan
visco-elastic
aqueous
vitreous humour

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.